Acquisition - February 5, 2015
Ginolis, JOT Life Science Merging
Ginolis, a manufacturer of diagnostic disposables, plans to acquire JOT Automation’s Life Science Division, the companies recently announced. The merger is scheduled to take place during the first half of this year. “The transaction is a win-win for both companies’ customers. It enables us to grow even more customer-centric and accelerates our time-to-market in our […]
Acquisition - February 5, 2015
AstraZeneca Teams with Box
AstraZeneca is making Box’s cloud content sharing and collaboration platform available to its 51,000 employees across more than 100 countries. The platform will provide secure collaboration company-wide and with external parties, as well as enable mobile access to information. “AstraZeneca’s move to Box follows our deep emphasis on life sciences, which is an important sector […]
Acquisition - February 5, 2015
Symphogen, Merck End Pact
Danish biotech company Symphogen once again has its lead asset in its portfolio, experimental cancer drug Sym004, three years after it partnered with Merck on a $625 million deal for its development. The two companies said recently that they have ended their collaboration, with Symphogen saying it hopes to now turn itself into a standalone […]
Acquisition - February 5, 2015
Share Issue for Ultimovacs
Norway’s Ultimovacs AS has carried out a successful NOK 45 million share issue with DNB Markets and Arctic Securities as financial advisors. The issue was fully subscribed by new shareholders. The two biggest new shareholders are Canica AS and Sundt AS. Ultimovacs is a biotechnology company that develops a therapeutic universal cancer vaccine. The treatment […]
Acquisition - February 5, 2015
Cortendo Gains Investors
Cortendo AB, a Swedish global biopharmaceutical company focused on orphan endocrine disorders, has entered agreements with U.S. institutional specialist healthcare investors RA Capital Management, New Enterprise Associates (NEA) and Broadfin Capital. HealthCap, a leading European venture capital healthcare investor, also agreed to increase its existing investment in the company, bringing this private placement to a […]
Acquisition - February 4, 2015
Ginolis, Canadian Firm Ink Deal
Ginolis Ltd. has delivered a development and production solution for point-of- care diagnostic tests to a Canada-based company that is operating in international markets. The tests are used for assessing cardiac risks and are already available internationally. The Ginolis solution provides increased production capacity and improved quality control with which the customer can respond to […]
